Filed Pursuant to Rule 433
Registration Statement No. 333-285483
Issuer Free Writing Prospectus dated June 18, 2026
VeriSign, Inc.
$550,000,000
5.100% Senior Notes due 2031
June 18, 2026
This pricing term sheet relates only to VeriSign, Inc.’s offering of its 5.100% Senior Notes due 2031 and should be read together with the Preliminary
Prospectus Supplement dated June 18, 2026 (the “Preliminary Prospectus Supplement”) and the accompanying Prospectus dated June 18, 2026. Terms used and not defined herein have the meanings assigned in the Preliminary Prospectus Supplement.
|
Issuer:
|
VeriSign, Inc.
|
|
Security:
|
5.100% Senior Notes due 2031
|
|
Anticipated Ratings (Moody’s/S&P)*:
|
Baa2 / BBB
|
|
Principal Amount:
|
$550,000,000
|
|
Maturity Date:
|
July 15, 2031
|
|
Interest Rate:
|
5.100%
|
|
Interest Payment Dates:
|
January 15 and July 15, commencing January 15, 2027
|
|
Public Offering Price:
|
99.961% of principal amount
|
|
Yield to Maturity:
|
5.108%
|
|
Spread to Benchmark Treasury:
|
+90 bps
|
|
Benchmark Treasury:
|
UST 4.125% due May 31, 2031
|
|
Benchmark Treasury Price / Yield:
|
99-20 ¼ / 4.208%
|
|
Make-Whole Call:
|
T+15 bps prior to June 15, 2031
|
|
Par Call:
|
On or after June 15, 2031
|
|
Change of Control Repurchase Event:
|
Put @ 101% of principal plus accrued and unpaid interest
|
|
Trade Date:
|
June 18, 2026
|
|
Settlement Date:
|
T+5; June 26, 2026
We expect that delivery of the notes will be made against
payment therefor on or about June 26, 2026, which is the fifth business day following the date of pricing of the notes (such settlement
cycle being referred to as “T+5”). Under Rule 15c6-1 under the Securities Exchange Act of 1934, as amended, trades in the secondary market
generally are required to settle in one business day unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the notes prior to the business day immediately before settlement will be
required to specify an alternative settlement cycle at the time of any such trade to prevent failed settlement and should consult their own advisors.
|
|
Denominations/Multiple:
|
$2,000 x $1,000
|
|
CUSIP / ISIN:
|
92343E AR3 / US92343EAR36
|
|
Joint Book-Running Managers:
|
J.P. Morgan Securities LLC
BofA Securities, Inc.
U.S. Bancorp Investments, Inc.
|
|
Use of Proceeds:
|
The Issuer intends to use the net proceeds from this offering, together with cash on hand, to fund the redemption of all of the outstanding 2027
Notes.
|
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction to any
person to whom it is unlawful to make such offer or solicitation in such jurisdiction.
The issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (the “SEC”) to which
this communication relates. Before you invest in any offering, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about Verisign and the offering. You may
get these documents for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, the issuer or any underwriter participating in the offering will arrange to send you the prospectus if you request it by calling J.P. Morgan Securities
LLC at (212) 834-4533, BofA Securities, Inc. at (800) 294-1322 or U.S. Bancorp Investments, Inc. at (877) 558-2607.
*A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.